Broad Pipeline of Investigational
Product Candidates
to Fight Cancer
Leading Multispecific Antibody
Technology Platforms
and Protein Engineering Expertise
Developing Breakthrough Biologics,
Fully-integrated, Antibody-based
Development Capabilities,
Including GMP Manufacturing
Focused on Developing
Innovative Medicines
for Patients with Unmet Needs

We are a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer.

Click on the link below for our latest corporate presentation.

We’re Hiring!

It’s an exciting time at MacroGenics — our new GMP manufacturing suite is operational and we are looking for additional manufacturing and quality professionals to join our team. Our pipeline is expanding, as are our development and clinical teams.

Click on link below for current opportunities.

Latest News

MacroGenics to Participate in Upcoming Investor Conference
Read More

MacroGenics Announces Appointment of William Heiden to Board of Directors
Read More

Please note – you will leave a website owned by MacroGenics, Inc.

MacroGenics is not responsible for any content on the third party website.

Ok Close